Author: Suthar, A.; Schubert, S.; Garon, J.; Couture, A.; Brown, A.; Charania, S.
Title: COVID-19 case definitions, diagnostic testing criteria, and surveillance across the pandemic's 25 highest burden countries Cord-id: 66lf3bmm Document date: 2021_5_14
ID: 66lf3bmm
Snippet: Objective: We compared suspect, probable, and confirmed case definitions, as well as diagnostic testing criteria, used in the COVID-19 pandemic's 25 highest burden countries to aid interpretation of global and national surveillance data. Methods: We identified the COVID-19 pandemic's 25 countries with the highest disease burden based on the number of cumulative reported cases to the World Health Organization (WHO) as of 1 October 2020. We searched official websites of these countries for suspect
Document: Objective: We compared suspect, probable, and confirmed case definitions, as well as diagnostic testing criteria, used in the COVID-19 pandemic's 25 highest burden countries to aid interpretation of global and national surveillance data. Methods: We identified the COVID-19 pandemic's 25 countries with the highest disease burden based on the number of cumulative reported cases to the World Health Organization (WHO) as of 1 October 2020. We searched official websites of these countries for suspect, probable, and confirmed case definitions. Given that confirmation of COVID-19 usually requires diagnostic testing, we also searched for diagnostic testing eligibility criteria in these countries. Extracted case definitions and testing criteria were managed in a database and analyzed in Microsoft Excel. Findings: We identified suspect, probable, and confirmed case definitions in 96%, 64%, and 100% of countries, respectively. Testing criteria were identified in 100% of countries. 56% of identified countries followed WHO recommendations for using a combination of clinical and epidemiological criteria as part of the suspect case definition. 75% of identified countries followed WHO recommendations on using clinical, epidemiological, and diagnostic criteria for probable cases. 72% of countries followed WHO recommendations on using PCR testing for confirming a case of COVID-19. Finally, 64% of countries used testing eligibility criteria at least as permissive as WHO. Conclusion: There is marked heterogeneity in who is eligible for testing in countries and how countries define a case of COVID-19. This affects the ability to compare burden, transmission, and response impact estimates derived from case surveillance data across countries.
Search related documents:
Co phrase search for related documents- abdominal pain and acute ari respiratory infection: 1
- abdominal pain and acute cardiac injury: 1, 2
- abdominal pain and acute kidney injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26
- abdominal pain and acute myocarditis: 1, 2, 3, 4, 5, 6, 7, 8
- abdominal pain and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- abdominal pain and acute respiratory infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39
- abdominal pain and livedo reticularis: 1
- abdominal pain and long term care facility: 1
- abdominal pain and loss impaired: 1
- abnormal echocardiogram and acute respiratory: 1
- abnormal echocardiogram and acute respiratory infection: 1
- acral ischemia and acute respiratory: 1
- acral ischemia and livedo reticularis: 1
- acute cardiac injury and livedo reticularis: 1
- acute cardiac injury and loss impaired: 1
- acute kidney injury and adapted version: 1
- acute kidney injury and livedo reticularis: 1
- acute kidney injury and local level: 1
- acute respiratory and adapted version: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date